Winton Group LTD Satsuma Pharmaceuticals, Inc. Transaction History

Winton Group LTD

  • $1.37 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 28, 2021
SELL
$4.54 - $7.17 $63,355 - $100,057
-13,955 Closed
0 $0
Q2 2021

Aug 10, 2021
SELL
$4.8 - $7.25 $13,622 - $20,575
-2,838 Reduced 16.9%
13,955 $98,000
Q1 2021

Jul 21, 2021
BUY
$4.57 - $7.18 $22,310 - $35,052
4,882 Added 40.99%
16,793 $99,000
Q4 2020

Feb 12, 2021
BUY
$3.56 - $5.09 $42,403 - $60,626
11,911 New
11,911 $55,000

About Satsuma Pharmaceuticals, Inc.

STSA Quotes by TradingView
  • Ticker STSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,587,500
  • Description
  • Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...
More about STSA
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email